PortfoliosLab logoPortfoliosLab logo
ISIN
US1167941087
CUSIP
116794108
IPO Date
Aug 4, 2000

Highlights

Market Cap
$8.75B
Enterprise Value
$10.30B
EPS (TTM)
-$0.17
Total Revenue (TTM)
$3.46B
Gross Profit (TTM)
$1.57B
EBITDA (TTM)
$224.20M
Year Range
$28.53 - $58.98
Target Price
$52.13
ROA (TTM)
-0.42%
ROE (TTM)
-1.05%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

BRKR Performance Chart

Bruker Corporation (BRKR) is up 21.8% since the beginning of the year. At $57 per share, BRKR is trading just below its 52-week high of $59. Investors who bought $1,000 worth of BRKR shares 5 years ago would now be looking at an investment worth $850.


Loading charts...

S&P 500 Index

Returns By Period

Bruker Corporation (BRKR) has returned 21.83% so far this year and 56.87% over the past 12 months. Over the last ten years, BRKR has returned 8.50% per year, falling short of the S&P 500 Index benchmark, which averaged 13.75% annually.


Bruker Corporation

1D
-1.93%
1M
55.78%
YTD
21.83%
6M
21.50%
1Y
56.87%
3Y*
-6.72%
5Y*
-3.20%
10Y*
8.50%

Benchmark (S&P 500 Index)

1D
0.13%
1M
5.25%
YTD
11.16%
6M
11.43%
1Y
28.20%
3Y*
21.12%
5Y*
12.66%
10Y*
13.75%
*Multi-year figures are annualized to reflect compound growth (CAGR)

BRKR Monthly Returns History

Based on dividend-adjusted daily data since Aug 4, 2000, BRKR's average daily return is +0.08%, while the average monthly return is +1.47%. At this rate, an investment would double in approximately 4.0 years.

Historically, 54% of months were positive and 46% were negative. The best month was Aug 2000 with a return of +117.9%, while the worst month was Oct 2008 at -69.3%. The longest winning streak lasted 11 consecutive months, and the longest losing streak was 5 months.

On a daily basis, BRKR closed higher 50% of trading days. The best single day was Jan 14, 2009 with a return of +35.2%, while the worst single day was Jan 8, 2001 at -31.8%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-5.99%-9.44%-9.81%1.63%60.42%-2.68%21.83%
2025-0.80%-18.80%-11.51%-4.02%-8.39%12.41%-6.72%-11.58%-4.24%19.85%25.35%-3.38%-19.24%
2024-2.68%21.09%8.55%-16.96%-16.02%-2.52%7.37%-1.85%2.78%-18.03%2.37%1.24%-19.99%
20232.59%-1.64%14.39%0.37%-12.61%6.98%-7.03%-4.47%-5.03%-8.51%14.28%12.89%7.82%
2022-20.63%5.73%-8.63%-10.59%8.76%0.45%9.23%-18.24%-5.25%16.55%9.09%1.39%-18.29%
20216.95%5.34%5.48%6.60%1.40%9.42%8.25%7.42%-11.56%2.82%0.91%3.61%55.35%

Benchmark Metrics

Bruker Corporation has an annualized alpha of 9.39%, beta of 1.22, and R2 of 0.18 versus S&P 500 Index. Calculated based on daily prices since August 07, 2000.

  • This stock captured 168.54% of S&P 500 Index gains and 155.54% of its losses - amplifying both gains and losses, but participating more in upside than downside.
  • R2 of 0.18 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
9.39%
Beta
1.22
0.18
Upside Capture
168.54%
Downside Capture
155.54%

Return for Risk

Risk / Return Rank

BRKR ranks 67 for risk / return — better than 67% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.


BRKR Risk / Return Rank: 6767
Overall Rank
BRKR Sharpe Ratio Rank: 7272
Sharpe Ratio Rank
BRKR Sortino Ratio Rank: 6868
Sortino Ratio Rank
BRKR Omega Ratio Rank: 6666
Omega Ratio Rank
BRKR Calmar Ratio Rank: 6767
Calmar Ratio Rank
BRKR Martin Ratio Rank: 6565
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Bruker Corporation (BRKR) and compare them to S&P 500 Index.


BRKRBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

1.06

2.39

-1.33

Sortino ratio

Return per unit of downside risk

1.65

3.25

-1.61

Omega ratio

Gain probability vs. loss probability

1.20

1.43

-0.23

Calmar ratio

Return relative to maximum drawdown

1.43

3.11

-1.68

Martin ratio

Return relative to average drawdown

2.79

14.38

-11.60

Dividends

Dividend History

Bruker Corporation provided a 0.35% dividend yield over the last twelve months, with an annual payout of $0.20 per share. The company has been increasing its dividends for 9 consecutive years.


0.20%0.30%0.40%0.50%0.60%0.70%0.80%$0.00$0.05$0.10$0.15$0.202016201720182019202020212022202320242025
Dividends
Dividend Yield
PeriodTTM2025202420232022202120202019201820172016
Dividend$0.20$0.20$0.20$0.20$0.20$0.16$0.16$0.16$0.16$0.16$0.16

Dividend yield

0.35%0.42%0.34%0.27%0.29%0.19%0.30%0.31%0.54%0.47%0.76%

Monthly Dividends

The table displays the monthly dividend distributions for Bruker Corporation. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026$0.00$0.00$0.05$0.00$0.00$0.00$0.05
2025$0.00$0.00$0.05$0.00$0.00$0.05$0.00$0.00$0.05$0.00$0.00$0.05$0.20
2024$0.00$0.05$0.00$0.00$0.00$0.05$0.00$0.05$0.00$0.00$0.00$0.05$0.20
2023$0.00$0.05$0.00$0.00$0.05$0.00$0.00$0.05$0.00$0.00$0.05$0.00$0.20
2022$0.00$0.05$0.00$0.00$0.05$0.00$0.00$0.05$0.00$0.00$0.05$0.00$0.20
2021$0.00$0.00$0.04$0.00$0.04$0.00$0.00$0.04$0.00$0.00$0.04$0.00$0.16

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Bruker Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Bruker Corporation was 94.83%, occurring on Mar 12, 2003. Recovery took 4103 trading sessions.

The current Bruker Corporation drawdown is 38.67%.


Related event

Drawdown

Fall

Recovery

Underwater

2003 bear market2003
-94.83%Mar 2003
2y 6mo16y 3mo
18y 10moSep 2000 - Jun 2019
2025 bear market2025
-68.72%Sep 2025
1y 5mo
2y 2moMar 2024 - now
Bear market2022
-46.31%Sep 2022
1y 19d1y 5mo
2y 6moSep 2021 - Mar 2024
COVID crash2020
-41.49%Apr 2020
2mo 15d8mo 10d
10mo 25dJan 2020 - Dec 2020
2019 bear market2019
-22.01%Aug 2019
1mo 7d3mo 15d
4mo 22dJul 2019 - Nov 2019

Drawdown Indicators


BRKRBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-94.83%

-56.78%

-38.05%

Max Drawdown (1Y)

Largest decline over 1 year

-39.85%

-9.10%

-30.75%

Max Drawdown (3Y)

Largest decline over 3 years

-68.72%

-18.90%

-49.82%

Max Drawdown (5Y)

Largest decline over 5 years

-68.72%

-25.43%

-43.29%

Max Drawdown (10Y)

Largest decline over 10 years

-68.72%

-33.92%

-34.80%

Current Drawdown

Current decline from peak

-38.67%

0.00%

-38.67%

Average Drawdown

Average peak-to-trough decline

-57.72%

-10.72%

-47.00%

Ulcer Index

Depth and duration of drawdowns from previous peaks

20.48%

1.97%

+18.51%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Bruker Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Bruker Corporation is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for BRKR relative to other companies in the Medical Devices industry. Currently, BRKR has a P/S ratio of 2.5. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for BRKR in comparison with other companies in the Medical Devices industry. Currently, BRKR has a P/B value of 3.5. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with BRKR

Add Bruker Corporation to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with BRKR